Gannon Randolph, MD
Orthopaedic Surgery of the Spine · Bentonville, ARNPI 1528173697
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $27,000 of the $38,953 with a category attached, or 69.3%. 13 manufacturers reported payments, led by Stryker at 51.8% of the total. Reporting peaked in 2019 at $25,709 and has fallen 99.9% since, to $17 in 2024.
Across 55 payments — averaging $708.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$20K
- Choice Spine, LLC$18K
- Abbott$192
- Boston Scientific$169
- Medtronic$161
- Centinel Spine, LLC$150
- plus $223 from 7 others
What the payments were for
- Royalty or licence$8,82323%
- Consulting fees$27,00069%
- Travel & lodging$1,5854%
- Food & beverage$1,5464%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 27 | $20,185 |
| Choice Spine, LLC | 7 | $17,873 |
| Abbott | 3 | $192 |
| Boston Scientific | 3 | $169 |
| Medtronic | 6 | $161 |
| Centinel Spine, LLC | 1 | $150 |
| Spineology Inc. | 1 | $52 |
| DJO, LLC | 1 | $46 |
| Smith+Nephew | 1 | $36 |
| Amgen | 2 | $30 |
| Si-bone, Inc. | 1 | $30 |
| Avanos Medical | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few orthopaedic surgery of the spine providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 73 | $1,421 |
| Mupirocin | 118 | $862 |
| Meloxicam | 171 | $605 |
| Cyclobenzaprine Hcl | 60 | $430 |
| Baclofen | 41 | $313 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $210 |
| Ondansetron OdtOndansetron | 27 | $111 |
| Methylprednisolone | 11 | $103 |
| Tamsulosin Hcl | 47 | $97 |
| Tizanidine Hcl | 11 | $85 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $14 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Bentonville
- Jared SealeLittle Rock$1M
- Mark FegerConway$13K
- Patrick ChanSearcy$8K
- Wayne BruffettNorth Little Rock$4K
- Richard PeekLittle Rock$955
- Edward SaerLittle Rock$364
- Travis RichardsonParagould$263
- David ArnoldConway$174
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.